Vaginal Misodel® in Comparison With Orally Administrated Misoprostol (Cytotec®) at Induction of Labour
NCT ID: NCT02918110
Last Updated: 2016-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
320 participants
INTERVENTIONAL
2016-09-30
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaginally Administered Versus Per Oral Misoprostol in Induction of Labour
NCT02539199
Labor Induction With Oral Versus Vaginal Misoprostol
NCT04755218
Oral Misoprostol Solution in Comparison to Vaginal Misoprostol in Induction of Labor
NCT03863392
Comparison of Oral Versus Vaginal Misoprostol for Labour Induction at Term
NCT05957666
Low-dose Vaginal Misoprostol Versus Vaginal Dinoprostone Insert for Induction of Labor
NCT03744364
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Settings:
Obstetric departments of Sodersjukhuset, Stockholm Obstetric departments of Women's clinic, Karlstad.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cytotec
orally administrated solution of misoprostol (Cytotec®)
Misoprostol
Women needed to be induced will get orally administrated solution of misoprostol (Cytotec®) or vaginal slow release misoprostol (Misodel®)
Misodel
vaginal slow release misoprostol (Misodel®)
Misoprostol
Women needed to be induced will get orally administrated solution of misoprostol (Cytotec®) or vaginal slow release misoprostol (Misodel®)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Misoprostol
Women needed to be induced will get orally administrated solution of misoprostol (Cytotec®) or vaginal slow release misoprostol (Misodel®)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karlstad Central Hospital
OTHER
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eva Wiberg-Itzel
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Per Tornvall, Prof
Role: STUDY_DIRECTOR
Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eva Wiberg-Itzel
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Strandberg M, Wallstrom T, Wiberg-Itzel E. Women's expectations and experiences of labor induction - a questionnaire-based analysis of a randomized controlled trial. BMC Pregnancy Childbirth. 2021 May 4;21(1):355. doi: 10.1186/s12884-021-03786-6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1cyt
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.